Reverse genetics using nonendogenous pol I promoters

Details for Australian Patent Application No. 2010250832 (hide)

Owner Novartis AG

Inventors Dormitzer, Philip; Franti, Michael; Suphaphiphat, Pirada; Mason, Peter; Keiner, Bjoern; Crotta, Stephania

Agent FB Rice

Pub. Number AU-A-2010250832

PCT Pub. Number WO2010/133964

Priority 61/216,919 21.05.09 US

Filing date 21 May 2010

Wipo publication date 25 November 2010

International Classifications

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

8 December 2011 PCT application entered the National Phase

  PCT publication WO2010/133964 Priority application(s): WO2010/133964

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010250838-Targeting microRNAs for metabolic disorders

2010250829-Infusion unit for making beverages from single-serving sachets and machine comprising said unit